查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1578283

全球镇咳药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Antitussive Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球镇咳药市场需求预计将从2023年的149551万美元达到2032年近237427万美元的市场规模，2024-2032年研究期间复合年增长率为5.27%。

镇咳药是一类异质药物，通常用于抑制呼吸系统疾病患者的干咳。镇咳药物可以治疗普通感冒、流感、过敏、花粉热或其他呼吸系统疾病（如鼻窦炎、支气管炎等）引起的各种症状。它们要不是鸦片类药物，就是鸦片类药物，如福尔可定、可待因和右美沙芬。最常用的非处方镇咳药之一是右美沙芬，它相对安全。它们是口服的，有糖浆、片剂或蒸气形式。这些药物不适合长期使用，因为它们有滥用的风险，甚至可能导致成瘾。

市场动态

大气污染率高和全球人口中呼吸系统疾病的盛行率不断上升是止咳药市场成长的主要刺激因素。个人咳嗽的传染性以及咳嗽是一个未被满足的重大医疗需求将进一步推动市场成长。由于持续咳嗽会损害人们的生活质量，因此镇咳药物的需求将稳定成长。这些药物的认知度提高和容易获得将有利于市场成长。继续研究生产廉价、有效且副作用最小的止咳药将阻碍该市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球镇咳药物市场的各个细分市场进行了包容性评估。镇咳药物产业的成长和趋势为本研究提供了整体方法。

市场区隔

镇咳药物市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按指示

  • 疼痛
  • 寒冷的
  • 咳嗽
  • 其他的

按药物类别

  • 週边作用药物
  • 中枢作用药物
  • 其他的

按药物分类

  • 右美沙芬
  • 苯佐那酯

依剂型分类

  • 平板电脑
  • 糖浆
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲镇咳药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。镇咳药市场的主要参与者包括辉瑞公司、强生公司、赛诺菲公司、葛兰素史克公司、默克公司、诺华国际公司、阿斯特捷利康公司、勃林格殷格翰国际有限公司、罗氏控股公司、拜耳公司、梯瓦製药Pharmaceutical Industries Ltd.、Sun Pharmaceutical Industries Ltd.、Mylan NV、Cipla Ltd.、Reckitt Benckiser Group Plc、Perrigo Company Plc、Glenmark Pharmaceuticals Ltd. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键技术併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：镇咳药物 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按指标进行的市场吸引力分析
    • 按药品类别分類的市场吸引力分析
    • 药品市场吸引力分析
    • 按剂型分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球镇咳药物市场分析：依适应症分类

  • 按指示概述
  • 历史和预测数据
  • 按指标分析
  • 疼痛
  • 寒冷的
  • 咳嗽
  • 其他的

第 6 章：全球镇咳药物市场分析：依药物类别

  • 按药物类别概述
  • 历史和预测数据
  • 按药物类别分析
  • 週边作用药物
  • 中枢作用药物
  • 其他的

第 7 章：全球镇咳药物市场分析：依药物分类

  • 按药物概述
  • 历史和预测数据
  • 按药物分析
  • 右美沙芬
  • 苯佐那酯

第 8 章：全球镇咳药物市场分析：按剂型

  • 按剂型概述
  • 历史和预测数据
  • 按剂型分析
  • 平板电脑
  • 糖浆
  • 其他的

第 9 章：全球镇咳药物市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：镇咳药公司的竞争格局

  • 镇咳药市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Johnson & Johnson
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sanofi SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GlaxoSmithKline Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck & Co. Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novartis International AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AstraZeneca Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Boehringer Ingelheim International GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Roche Holding AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bayer AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Teva Pharmaceutical Industries Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sun Pharmaceutical Industries Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Mylan NV
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cipla Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Reckitt Benckiser Group Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Perrigo Company Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Glenmark Pharmaceuticals Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11213977

The global demand for Antitussive Drugs Market is presumed to reach the market size of nearly USD 2374.27 Million by 2032 from USD 1495.51 Million in 2023 with a CAGR of 5.27% under the study period 2024-2032.

Antitussive drugs are a class of heterogeneous medications generally used to suppress dry cough in patients suffering from respiratory disorders. Antitussive drugs can cure various symptoms caused by the common cold, flu, allergies, hay fever, or other breathing disorders like sinusitis, bronchitis, etc. These drugs reduce the urge to cough in patients by acting on the cough center in the brain. They are either opiates or opioids like pholcodine, codeine, and dextromethorphan. One of the most used over-the-counter antitussive drugs is Dextromethorphan, and it is relatively safe. They are taken orally and are available in the form of syrup, tablets, or vapor. These drugs are not suitable for long-term use since they risk abuse and may even cause addiction.

MARKET DYNAMICS

A high rate of atmospheric pollution and the growing prevalence of respiratory disorders among the global population is the central stimulant for the growth of the cough suppressants market. The contagious nature of individual coughs and cough being a significant unmet medical need will further propel market growth. The demand for antitussive drugs will see a steady increase since persistent cough can harm a person's quality of life. Rising awareness and easy availability of these drugs will benefit market growth. Continuing research to produce cheap, effective cough suppressants with minimal side effects will hinder this market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antitussive Drugs. The growth and trends of Antitussive Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antitussive Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

  • Pain
  • Cold
  • Cough
  • Others

By Drug Class

  • Peripherally Acting Drugs
  • Centrally Acting Drugs
  • Others

By Drug

  • Dextromethorphan
  • Benzonatate

By Dosage Form

  • Tablets
  • Syrup
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antitussive Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antitussive Drugs market include Pfizer Inc., Johnson & Johnson, Sanofi S.A., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis International AG, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Roche Holding AG, Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Cipla Ltd., Reckitt Benckiser Group Plc, Perrigo Company Plc, Glenmark Pharmaceuticals Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ANTITUSSIVE DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Indication
    • 3.7.2 Market Attractiveness Analysis By Drug Class
    • 3.7.3 Market Attractiveness Analysis By Drug
    • 3.7.4 Market Attractiveness Analysis By Dosage Form
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY INDICATION

  • 5.1. Overview By Indication
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Indication
  • 5.4. Pain Historic and Forecast Sales By Regions
  • 5.5. Cold Historic and Forecast Sales By Regions
  • 5.6. Cough Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DRUG CLASS

  • 6.1. Overview By Drug Class
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Drug Class
  • 6.4. Peripherally Acting Drugs Historic and Forecast Sales By Regions
  • 6.5. Centrally Acting Drugs Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DRUG

  • 7.1. Overview By Drug
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Drug
  • 7.4. Dextromethorphan Historic and Forecast Sales By Regions
  • 7.5. Benzonatate Historic and Forecast Sales By Regions

8. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DOSAGE FORM

  • 8.1. Overview By Dosage Form
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Dosage Form
  • 8.4. Tablets Historic and Forecast Sales By Regions
  • 8.5. Syrup Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTITUSSIVE DRUGS COMPANIES

  • 10.1. Antitussive Drugs Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ANTITUSSIVE DRUGS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pfizer Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Johnson & Johnson
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Sanofi S.A.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. GlaxoSmithKline Plc
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Merck & Co. Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Novartis International AG
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. AstraZeneca Plc
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Boehringer Ingelheim International GmbH
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Roche Holding AG
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Bayer AG
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Teva Pharmaceutical Industries Ltd.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Sun Pharmaceutical Industries Ltd.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Mylan N.V.
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Cipla Ltd.
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Reckitt Benckiser Group Plc
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Perrigo Company Plc
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments
  • 11.19. Glenmark Pharmaceuticals Ltd
    • 11.19.1 Company Overview
    • 11.19.2 Company Revenue
    • 11.19.3 Products
    • 11.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Indication (USD MN)
  • Pain Market Sales By Geography (USD MN)
  • Cold Market Sales By Geography (USD MN)
  • Cough Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Drug Class (USD MN)
  • Peripherally Acting Drugs Market Sales By Geography (USD MN)
  • Centrally Acting Drugs Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Drug (USD MN)
  • Dextromethorphan Market Sales By Geography (USD MN)
  • Benzonatate Market Sales By Geography (USD MN)
  • Analysis By Dosage Form (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Syrup Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Antitussive Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Antitussive Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Antitussive Drugs Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Drug
  • Market Attractiveness Analysis By Dosage Form
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Indication (USD MN)
  • Pain Market Sales By Geography (USD MN)
  • Cold Market Sales By Geography (USD MN)
  • Cough Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Class (USD MN)
  • Peripherally Acting Drugs Market Sales By Geography (USD MN)
  • Centrally Acting Drugs Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug (USD MN)
  • Dextromethorphan Market Sales By Geography (USD MN)
  • Benzonatate Market Sales By Geography (USD MN)
  • Global Market Analysis By Dosage Form (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Syrup Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.